OPTIMIZATION OF THE TECHNOLOGY OF "PHOSFARGININE SUCCINATE" INFUSION SOLUTION
OPTIMIZATION OF THE TECHNOLOGY OF "PHOSFARGININE SUCCINATE" INFUSION SOLUTION release_aed2whyydrcppdhnjsfibbol24

by V.R. Khaydarov, Candidate Of Pharmaceutical Sciences, Professor Of The Department Of Industrial Technology Of Medicines Tashkent Pharmaceutical Institute, Uzbekistan, N.S. Fayzullaeva, F.Kh. Maksudova, Sh.B. Yusupova, Candidate Of Pharmaceutical Sciences, Associate Professor Of The Department Of Technology Of Dosage Forms Tashkent Pharmaceutical Institute, Uzbekistan, Doctor Of Pharmacy (Dsc), Associate Professor Of The Department Of Industrial Technology Of Medicines Tashkent Pharmaceutical Institute, Uzbekistan, Assistant Of The Department Of Industrial Technology Of Medicines Tashkent Pharmaceutical Institute, Uzbekistan

Published in The American Journal of Applied Sciences by The USA Journals.

2022   Volume 04, Issue 11, p09-23

Abstract

In recent years, much attention has been paid to providing the population with domestically produced pharmaceuticals, the production of new import-substituting drugs that are affordable from an economic point of view, important tasks have been identified for "the development of the pharmaceutical industry, as well as improving the provision of the population and medical institutions with cheap, high-quality drugs". In this regard, the search for new drugs, their introduction into the pharmaceutical industry is being carried out. One of these drugs is "Phosfarginine succinate" (consisting of D-fructose-1,6-diphosphate trisodium salt, L-arginine hydrochloride, succinic acid) infusion solution - a drug that stimulates and regulates the metabolic process. The infusion solution technology was developed on the basis of Temur Med Farm LLC (Republic of Uzbekistan). In order to select a scientifically based composition, develop and optimize the technological process, the method of mathematical planning of the experiment was used - Latin plans. The application of the method of mathematical planning of the experiment made it possible to select the optimal composition and technology of the infusion solution "Phosfarginine succinate".
In application/xml+jats format

Archived Files and Locations

application/pdf   682.1 kB
file_nflvyidwhnb6vpcpcp4vq7c4ie
theamericanjournals.com (publisher)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2022-11-01
Journal Metadata
Not in DOAJ
Not in Keepers Registry
ISSN-L:  2689-0992
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 30ba8de2-b5f0-4824-a356-708628835075
API URL: JSON